
“Deborah agreed to take part in a trial as she was keen to help other cancer patients in the future. "If taking part in a trial means others might be helped then I’m very happy with that."
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This trial is looking at the risks or benefits of extending the age when women are invited for breast screening.
At present, all women between the ages of 50 and 70 are invited for breast screening as part of the NHS Breast Screening Programme (NHSBSP). In this trial the age range is being extended to include women between the ages of 47 and 49 and 71 to 73. Researchers hope to learn the risks and benefits of inviting women in these age ranges for additional screening.
The age extension to the NHSBSP (AgeX) is taking place in 65 Breast Screening Units across England. During the study, half the women between the ages of 47 to 49, and half the women between the ages of 71 to 73 will be to have breast screening. Some women between the ages of 74 and 79, and who have previously been invited for breast screening, may also be invited for an extra screen.
Researchers will collect information about the number of women who are diagnosed with breast cancer and the number of women who die of the disease.
The aim of this study is to see if extending the age range of breast screening reduces deaths from breast cancer.
More information about this study is available on www.agex.uk.
You may be invited to enter this study if you
This study is taking place at 65 Breast Screening Units in England. In these areas:
It is a randomised study. Women are put into groups by a computer. You cannot decide which group you are in. Women over 70 can ask to have breast screening every 3 years wherever they live.
If you receive an invite and decide to attend for screening, you will have at least 1 extra visit to the screening unit.
Although having an extra means you will be exposed to more X-rays, the NHSBSP says there is no current evidence to suggest that the risk of this exposure outweighs the benefits of breast screening.
We have more information about having a mammogram.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Julietta Patnick
Public Health England
NHS Breast Screening Programme
University of Oxford
Cancer Research UK
Freephone 0808 800 4040
“Deborah agreed to take part in a trial as she was keen to help other cancer patients in the future. "If taking part in a trial means others might be helped then I’m very happy with that."